ADAGE CAPITAL PARTNERS GP, L.L.C.
Position in PTGX — Protagonist Therapeutics, Inc
CIK 1165408
Boston, MA
Position in PTGX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$29,768,754
+$9,432,858 QoQ
Shares Held
282,436
+21.3% QoQ
Ownership
0.436%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ADAGE CAPITAL PARTNERS GP, L.L.C. holds $4,240,035,723 across 126 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
10,349,328 | $366,262,717 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
1,015,480 | $339,972,549 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
393,964 | $195,693,737 | |
| 4 | TNGX |
Tango Therapeutics, Inc.
|
5,600,000 | $175,056,000 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
2,252,000 | $167,728,960 | |
| 6 | SYRE |
Spyre Therapeutics, Inc.
|
1,722,300 | $152,905,794 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
2,569,356 | $145,965,114 | |
| 8 | RPRX |
Royalty Pharma plc
|
2,500,000 | $140,175,000 |
All Filings in PTGX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $29,768,754 | 282,436 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $20,335,896 | 232,836 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $47,710,158 | 718,202 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $60,369,320 | 1,092,262 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $16,611,853 | 343,504 | Shares | Sole | 2025-05-15 | |
| 2024-09-30 | $54,040,095 | 1,200,891 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $69,346,500 | 2,001,342 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $64,191,851 | 2,218,868 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $29,618,703 | 1,291,701 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $11,676,000 | 700,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $35,704,677 | 1,292,711 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $58,834,000 | 2,558,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $8,368,460 | 767,045 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $7,359,769 | 873,045 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $7,910,355 | 1,000,045 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $14,209,065 | 600,045 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $15,391,539 | 450,045 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $5,316,797 | 300,045 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $24,686,019 | 550,045 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $15,541,165 | 600,045 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $23,184,907 | 1,150,045 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $49,277,730 | 2,520,600 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $38,852,000 | 2,200,000 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||